Responsibility
Supporting society, people and communities around the world is fundamental to our long-term success.
We run to, not from, the world’s biggest health challenges
From finding solutions for some of the world’s most debilitating diseases, to getting our medicines and vaccines to those in need and building more effective health systems, we are always on a mission to create a better world.
As we work toward a greener future, it is vital that we consider the impact of our operations and strive to operate our business sustainably to support the health of our planet and its people. Our work to reduce our greenhouse gas emissions, achieve carbon neutrality, and ensure our science advances health care by reaching those most in need, represent our commitments to delivering greater value to society.
Operating responsibly is fundamental to our long-term success, to our obligation to society, and to the health and well-being of patients globally. To learn more, read our ESG/Impact Report and Carbon Reduction plan:
MSD Carbon Reduction Plan 23/24 MSD Carbon Reduction Plan 22/23 MSD Carbon Reduction Plan 21/22
MSD For Mothers
Focused on improving the health and wellbeing of mothers during pregnancy and childbirth, MSD for Mothers is a global initiative helping to create a world where no woman has to die while giving life. In the UK, our ‘Mumma Kits’ containing essentials for neonatal care are donated annually to a UK charity and distributed to mothers and babies.
Globally, MSD for Mothers is a $650 million initiative. This effort has so far provided more than thirty million women with improved access to affordable, quality care.
40 hours of paid volunteering
We encourage employees to make an impact outside of their daily role with our 40 hour paid volunteering policy, where they can volunteer time towards supporting charities and not-for-profit organisations that matter to them.
Empowering colleagues to make a difference in their own community, our involvement includes projects such as school education programmes, beach cleans, and mountain rescues.
Read more:
Diversity in clinical trials
We are pursuing new ways to recruit and engage clinical trial participants who are racially, socioeconomically, and demographically representative of the communities we aim to serve. It is vital that we have diverse representation in our research efforts so that our treatments’ efficacy is reflective of real-world populations.
Cancer patient outcomes
We work collaboratively with the NHS across the UK to improve cancer patients’ outcomes. Through numerous activities, we work together to improve patients’ and the public’s awareness of cancer signs and symptoms, to understand and to improve cancer pathways and to improve treatment uptake.
Striving for Hepatitis C elimination
MSD is helping deliver Hepatitis C elimination in England. Our approach involves close collaboration with the healthcare system to deliver elimination initiatives including point of care testing, patient search identification, peer to peer support and working with Operational Delivery Networks (ODNs) to recruit Community Liaison Officers
Striving to improve our Health Literacy
MSD is proud to be the first pharmaceutical company to complete accreditation to the PIF TICK – the UK’s quality mark for health information. This demonstrates our commitment to achieving excellence in the accuracy, coherence, and simplicity of the healthcare information we provide to public and patients in the UK. PIF TICK is an important part of helping to ensure clarity of information for those wanting to access healthcare information, regardless of their background.
And it’s not just UK communities that we support.
MSD Fellowship for Global Health
The MSD Fellowship for Global Health is a three-month, field-based pro bono programme designed to share the skills and talents of our employees worldwide. Each year, around 30 employees from around the world are selected as fellows and placed on teams to support the efforts of non-governmental organizations (NGOs).
The programme has touched thousands of lives in underserved communities around the world by developing and executing creative and sustainable solutions to some of the world’s most pressing health problems.
Eliminating river blindness
Since 1987, we’ve also been committed to donate as much medicine as needed to help eliminate river blindness in affected areas in Africa, Latin America and Yemen. In 2023, we reached approximately 178.5 million people.
As a result, four countries – Colombia, Ecuador, Mexico, Guatemala – have received WHO verification of river blindness elimination.
Find out more about…
GB-NON-10672 | December 2024